The Problem
Most Vision Loss is Preventable
An estimated 80 million people in the US general population have vision loss due to disease (diabetes, macular degeneration, etc.).
There is only 1 Eye Specialist for every 17,000 Americans.
It’s estimated that, only 40% of patients had their annual eye exam.
Our Strategy
3 Tiered Approach
Tier 1
Diabetic Patients
Enables the screening of Diabetic Retinopathy for patients with Type 1 and Type 2 diabetes.
Tier 2
Expand to Eyecare Diagnostics
Enables the screening of Age-Related Macular Degeneration, Optic Nerve suspicious for Glaucoma, etc.
Tier 3
Global Analytics
Enables the screening of Parkinson’s, Stroke, Heart Disease, and Kidney Disease, etc.
Our Solution
The Spect Platform
Today, we invented a vertically integrated platform from the ground up that solves all the pain-points that are routine with conventional retinal exams.
This exam is reimbursable through CPT billing, satisfies quality metrics (HEDIS/MIPs), and can be used for value based care.
Current Solutions:
Built for Specialists
Current solutions are inflexible, costly, and difficult to use.
Quality Results
Image gradability around 50-60%
Intensive Setup Costs
Hours of training, difficult to integrate in clinical workflow, immobile
Large Upfront Capital Expense
Starting price from $5,000+
Our Solution:
Built for all Healthcare Staff
Our solution is a frictionless workflow and enables all healthcare staff to obtain quick results.
Quick Quality Results
Exams in 3 minutes or less and Image gradability above 95%
No Initial Setup Costs
Hours of training, difficult to integrate in clinical workflow, immobile
No Capital Expense
Cost financed through a low monthly fee or other payment structure that meets your needs
Screenable Diseases with our Platform
We’re always looking to expand the diseases our platform tracks.
Common Eye Diseases
- Stages of Diabetic Retinopathy with and without macular edema
- Stages of Dry Macular Degeneration
- End Stage Wet Macular Degeneration
- Myopic Degeneration
- Epiretinal Membrane
- Retinal Vein Occlusion
Rarer Eye Diseases
- Choroidal Nevus
- Macular Hole
- Optic Nerve suspicious for Glaucoma
- Optic Disc Edema
- And Many More
Markets We Serve
The Spect solution is proudly deployed in over 8 states and 10 cities in the United States. We are heavily focused on screening the Senior Population.
